Intraocular pressure-lowering effects of commonly used fixed-combination drugs with timolol: a systematic review and meta-analysis. - Wikidata - wikimedia - TriplyDB

Intraocular pressure-lowering effects of commonly used fixed-combination drugs with timolol: a systematic review and meta-analysis.

Intraocular pressure-lowering effects of commonly used fixed-combination drugs with timolol: a systematic review and meta-analysis.

http://www.wikidata.org/entity/Q34428023

about

24-h Efficacy of Glaucoma Treatment Options Combination of brinzolamide and brimonidine for glaucoma and ocular hypertension: critical appraisal and patient focus Prospective, non-interventional, multicenter study of the intraocular pressure-lowering effects of prostaglandin analog/prostamide-containing therapies in previously treated patients with open-angle glaucoma or ocular hypertension.A genome-wide association study of intra-ocular pressure suggests a novel association in the gene FAM125B in the TwinsUK cohort Efficacy and safety of benzalkonium chloride-free fixed-dose combination of latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension.Efficacy and tolerability of fixed-combination brinzolamide/timolol in Latin American patients with open-angle glaucoma or ocular hypertension previously on brimonidine/timolol fixed combination.A 6-month study comparing efficacy, safety, and tolerability of the preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% versus each of its individual preservative-free components.The effect of vasopressin on ciliary blood flow and aqueous flow.Efficacy and tolerability of the fixed combinations latanoprost/timolol versus dorzolamide/timolol in patients with elevated intraocular pressure: a meta-analysis of randomized controlled trials.Fixed combination of latanoprost and timolol vs the individual components for primary open angle glaucoma and ocular hypertension: a systematic review and meta-analysis Fixed-combination treatments for intraocular hypertension in Chinese patients - focus on bimatoprost-timolol.Brinzolamide/timolol versus dorzolamide/timolol fixed combinations: A hospital-based, prospective, randomized study Long-term assessment of prostaglandin analogs and timolol fixed combinations vs prostaglandin analogs monotherapy Efficacy and Tolerability of Travoprost 0.004%/Timolol 0.5% Fixed-Dose Combination for the Treatment of Primary Open-Angle Glaucoma or Ocular Hypertension Inadequately Controlled with Beta-Blocker Monotherapy How ocular surface disease impacts the glaucoma treatment outcome Latanoprost/timolol fixed combination for the treatment of glaucoma.Latanoprost in the treatment of glaucoma.Point-of-care monitoring of perioperative intraocular pressure using portable tonometry in a patient with Posner-Schlossman syndrome: a case report Cyclic RGD peptides target human trabecular meshwork cells while ameliorating connective tissue growth factor-induced fibrosis.Glaucoma drainage implant surgery and ocular surface transplant graft preservation.Brimonidine and brinzolamide for treating glaucoma and ocular hypertension; a safety evaluation.Selective Laser Trabeculoplasty vs. Fixed Combinations with Timolol in Practice: A Replacement Study in Primary Open Angle Glaucoma.Safety and efficacy of a fixed versus unfixed brinzolamide/timolol combination in Japanese patients with open-angle glaucoma or ocular hypertension.Pre- and postsynaptic effects of brimonidine on isolated rabbit iris dilator muscles Efficiency, safety, and patient preference of switching from dorzolamide 1%/timolol 0.5% to brinzolamide 1%/timolol 0.5% while maintaining the prostaglandin F2α analog.Combination therapy of autologous adipose mesenchymal stem cell-enriched, high-density lipoaspirate and topical timolol for healing chronic wounds.A Phase III Randomized Clinical Trial of a 0.5% Timolol + 0.2% Brimonidine + 2.0% Dorzolamide Fixed Combination, Preservative-Free Ophthalmic Solution vs. 0.5% Timolol + 0.2% Brimonidine + 2.0% Dorzolamide Fixed Combination in Patients with Controll Ocular hypotensive effects of prostaglandin analogs in Japanese patients with normal-tension glaucoma: a literature review Initial intraocular pressure reduction by mono- versus multi-therapy in patients with open-angle glaucoma: results from the Glaucoma Intensive Treatment Study

P2860

Q26766594-2F9EB264-672F-4D6C-8EF6-60B4C4701391 Q26830201-AB2C8857-9255-4485-975A-307206CBEACC Q33596855-4547F6F7-348E-484B-906D-A30C476DF2E1 Q33649345-0B590FD2-7B03-41ED-8032-3F42C07EB54E Q33857744-644849EE-C0AD-4F51-A0D9-69FD471A1415 Q34253481-D3C76F60-5A79-45EC-998B-8E7CADC586A1 Q34737181-A1AB7B88-09E5-4317-B650-DDDC8AB7E35D Q35064776-93C57823-DE16-4E2D-AB25-9537C9398444 Q35071041-B864A58A-61B9-4E92-AE0D-E982E3EE3E58 Q35370679-92B3EB65-B6BF-42E2-9130-6F0F17C84442 Q35617544-79CD9B9F-BBA9-4480-BB4F-3FAF43198187 Q35981031-E3F038CB-85AB-40CA-8077-9CA4E0461877 Q36044733-F0574C78-F8B2-4161-A3D8-0C6234DA8F29 Q36291171-B70AD0F1-51A5-41F0-BB25-E2A323728AFA Q37259818-7B5FEF4B-C865-415A-842A-87F23FCFEF28 Q38117401-D6B49224-49CD-462A-9700-6D167FB3E3DB Q38261310-96E8D4C8-9C2E-4BF0-BB29-CDFAF6475B36 Q38439371-944DF041-FBB3-4F55-BFD1-9F954E9BAEA0 Q38786663-775DE8AE-3311-4DA8-817C-1E551AE6A280 Q39334781-EC778C2A-4E1C-440D-A4A0-EB38E5B87DDD Q39401937-9CB76ACC-2BE4-4729-8C6E-15A610DF1610 Q41464391-7F1085C6-4664-465F-8025-E3DB23AB3001 Q41877762-8A2AF1C8-261A-45D3-8D31-06442A39C247 Q42782559-AEA2C96B-D5EB-454E-A64D-5A43B04DD1B0 Q43190257-64A0F97F-B1C7-409B-A411-D918FC79F52E Q46060131-AB5DEEAC-EFFB-47C9-99A8-466C17076DA9 Q55375940-EAEE2E79-DEE0-4616-B22F-7285A1E09858 Q57071071-676650DB-CB5C-4FB7-9241-0A47D869E413 Q59137785-A5EE5E25-FCB3-4217-A8C2-C715B304487D

P2860

Intraocular pressure-lowering effects of commonly used fixed-combination drugs with timolol: a systematic review and meta-analysis.

http://www.wikidata.org/entity/Q34428023

description

2012 nî lūn-bûn

@nan

2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Intraocular pressure-lowering ...... atic review and meta-analysis.

@ast

Intraocular pressure-lowering ...... atic review and meta-analysis.

@en

Intraocular pressure-lowering ...... atic review and meta-analysis.

@nl

type

label

Intraocular pressure-lowering ...... atic review and meta-analysis.

@ast

Intraocular pressure-lowering ...... atic review and meta-analysis.

@en

Intraocular pressure-lowering ...... atic review and meta-analysis.

@nl

prefLabel

Intraocular pressure-lowering ...... atic review and meta-analysis.

@ast

Intraocular pressure-lowering ...... atic review and meta-analysis.

@en

Intraocular pressure-lowering ...... atic review and meta-analysis.

@nl

P1433

Q34428023-D9055AC2-96A1-4D5C-8DA4-FE84758F23CE

P1476

Q34428023-9E597584-EF82-42BC-917E-7A4C265F379A

P2093

Q34428023-09875C00-2DD6-4368-8C5C-6984860B4330

Q34428023-5F0C04E0-D41E-4939-A589-740ED5E04EC5

Q34428023-A1543851-87DB-4434-B962-40DCD491E84D

Q34428023-D6BACD00-FAE8-4FB0-AE27-2219508309BF

Q34428023-E8396732-EFB8-43FD-A580-7ECCFF6FFC88

P275

Q34428023-F532AFC4-B646-40AD-993C-7CE12A1CA733

P2860

Q34428023-05F20689-0AC7-4D0C-BF40-460B66B02FBD

Q34428023-06AEEFDE-48B5-48FC-9C24-74F26C8F348C

Q34428023-10046B96-D301-44CA-9AED-BAEC120A62F0

Q34428023-105E0A0B-537F-4418-B4BF-CD6A210E55EF

Q34428023-1884A764-D467-4946-ABEE-3CD1A7F097E4

Q34428023-1D703E43-B7F6-41CD-9802-56F52EC48145

Q34428023-24F37D9E-FA39-4D85-830A-0B2B4C1EAB85

Q34428023-28D55F60-66BF-4C03-836A-3A09EBEA6C99

Q34428023-2E80BCA4-B312-472E-8098-3914DF2CDE74

Q34428023-46857452-9E96-4E36-8E13-D1FE4D0D09DC

P304

Q34428023-7F6C63D0-1C0A-475C-AE9F-01011AE4AE23

P31

Q34428023-02990849-083A-4928-B201-2F776469DB72

Q34428023-D96BCA6D-5074-4547-A0D9-7C91EAEED5B0

Q34428023-c4eedc3d-5bbb-44dd-b331-687e3e21a5d2

P356

Q34428023-FB0D5E65-DF67-4834-BD03-0F7D4EEDA8D7

P407

Q34428023-39F948EA-A47E-46DE-B4FC-ABE3534E131F

P433

Q34428023-358B9E8B-D569-432F-9291-9E1196BA45F7

P478

Q34428023-6C026A23-C9E8-47F5-B0A7-495D4259BE12

P577

Q34428023-67CE515D-CAAF-4AA8-B473-56B8816658D0

P5875

Q34428023-145C22CF-ACFB-4F18-9CB9-9973C4622EEB

P698

Q34428023-9896A575-433D-4A0F-8762-152A8E6807A0

P921

Q34428023-137DE680-14EF-4C69-B2E6-8F28AB9D0217

Q34428023-2A06FDCB-A608-4B58-BE36-F7A81165B780

Q34428023-3C30F428-D4D4-488B-8F6B-2390B0A7230C

Q34428023-7343F348-D961-46F8-9B3C-D43EE38EC5B3

Q34428023-BDF68E23-5422-4574-B37A-3D65F60B7E3D

P932

Q34428023-FA093A65-7E13-4ADD-8537-BF89755C3D28

P356

JOURNAL.PONE.0045079

P1433

P1476

Intraocular pressure-lowering ...... atic review and meta-analysis.

@en

P2093

Guo-Cai Lu

http://www.w3.org/2001/XMLSchema#string

Jin-Wei Cheng

http://www.w3.org/2001/XMLSchema#string

Lian-Di Gao

http://www.w3.org/2001/XMLSchema#string

Rui-Li Wei

http://www.w3.org/2001/XMLSchema#string

Shi-Wei Cheng

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

The number of people with glaucoma worldwide in 2010 and 2020

Use of fixed-dose combination drugs for the treatment of glaucoma.

Can we rely on the best trial? A comparison of individual trials and systematic reviews.

Intraocular pressure-lowering effects of all commonly used glaucoma drugs: a meta-analysis of randomized clinical trials.

Twice-daily 0.2% brimonidine-0.5% timolol fixed-combination therapy vs monotherapy with timolol or brimonidine in patients with glaucoma or ocular hypertension: a 12-month randomized trial.

Randomized trial comparing three fixed combinations of prostaglandins/prostamide with timolol maleate.

A comparison of the fixed combination of latanoprost and timolol with the unfixed combination of brimonidine and timolol in patients with elevated intraocular pressure. A six month, evaluator masked, multicentre study in Europe.

Fixed combinations of topical glaucoma medications.

Intraocular pressure-lowering efficacy of brinzolamide 1%/timolol 0.5% fixed combination compared with brinzolamide 1% and timolol 0.5%.

Efficacy and safety of travoprost/timolol vs dorzolamide/timolol in patients with open-angle glaucoma or ocular hypertension.

P304

e45079

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0045079

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2012-09-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

231815114

http://www.w3.org/2001/XMLSchema#string

P698

23028770

http://www.w3.org/2001/XMLSchema#string

P921

heterocyclic compound

P932

3441590

http://www.w3.org/2001/XMLSchema#string